MedTrace Logo

SpinChip Hs-cTnI Multisite Precision

NCT06851013 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2025-05-14

No results posted yet for this study

Summary

During a heart attack, the protein troponin I is released from the heart muscle into the bloodstream. Measurements of cardiac troponin in blood are used as an aid in the diagnosis of heart attack. The SpinChip hs-cTnI test is a new high-sensitive test for measuring the amount of cardiac troponin I in the bloodstream as an aid in the diagnosis of heart attack.

The purpose of this study is to establish the precision of the SpinChip hs-cTnI test when using Li-Heparin plasma and whole blood samples in the hands of the intended user in the intended use setting at multiple sites.

Conditions

  • Acute Myocardial Infarction (AMI)

Interventions

DIAGNOSTIC_TEST

SpinChip hs-cTnI

SpinChip Platform, consisting of the SpinChip hs-cTnI test (self-contained cartridge) and SpinChip Analyzer (instrument)

Sponsors & Collaborators

  • Aurevia

    collaborator INDUSTRY

  • SpinChip Diagnostics ASA

    lead INDUSTRY

Principal Investigators

  • Hlge Røsjø, MD/Professor · Akershus University Hospital, Akershus Clinical Research Center (ACR), Norway

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-03
Primary Completion
2025-03-28
Completion
2025-03-28

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06851013 on ClinicalTrials.gov